Green debt base continues to attract gold! Since the beginning of this year, the issuance scale has approached 44 billion yuan. On December 12th, HSBC Jintrust Fund announced that HSBC Jintrust Green Bond Fund was formally established, with the initial raising scale of 5.98 billion yuan. In the first half of this year, the public offering market has issued four green debt bases-Manulife China Bond Green inclusive finance Preferred Index, Oriental China Bond Green Inclusive Theme Financial Preferred Index, Guofu China Bond Green inclusive finance Index and Jiashi China Bond Green Inclusive Theme Financial Preferred Index. Wind data shows that the total issuance scale of these four products reached 31.963 billion yuan, which set off a small climax of debt-based issuance at that time. So far, the issuance scale of green debt base has approached 44 billion yuan during the year. It can be expected that more green debt bases will meet with investors in the future. (CSI Taurus)The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.The trading of traditional Chinese medicine has increased the daily limit of Panlong Pharmaceutical, the trading of traditional Chinese medicine has increased, Panlong Pharmaceutical has increased its daily limit, Xiangxue Pharmaceutical has increased by over 9%, and Kunyao Group, Weikang Pharmaceutical, Huasen Pharmaceutical and Xinguang Pharmaceutical have followed suit.
In 2024, the qualification examination and approval of the first batch of new materials insurance compensation was started, and the Ministry of Industry and Information Technology recently issued a notice to organize the qualification examination and approval of the first batch of new materials insurance compensation in 2024. It is clear that the enterprise applying for qualification should be an enterprise that produces and manufactures the products listed in the Catalogue for the Demonstration and Guidance of the First Application of Key New Materials (2024 Edition). It belongs to an independent legal person registered in People's Republic of China (PRC), has strong design and development, manufacturing and industrialization capabilities, has a relatively complete team of professional technicians, and has mastered the core technology and intellectual property rights of this product development. The qualification examination and approval procedures need to go through three steps: enterprise declaration, review by local industrial and information authorities or recommended units such as the central enterprise group, and expert review organized by the Ministry of Industry and Information Technology. After review, the product compensation qualification is determined, and the amount of subsidy funds is approved according to a certain proportion of the product value, and the effective period is no more than 3 years.The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.Trump said that he chose Kari Lake as the director of VOA.
The National Green Development Fund and other companies have established ecological restoration production and investment partnerships. According to the enterprise survey APP, recently, Jiangxi Green Gold Ecological Restoration Industry Investment Partnership (Limited Partnership) was established with a capital contribution of 1 billion yuan, and its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the company is jointly owned by National Green Development Fund Co., Ltd. and Jiangxi Jinkong Investment Group Co., Ltd.Shennong Group has set up a new trading subsidiary in Guangxi. The enterprise search APP shows that recently, Guangxi Shennong Haiyun Trading Co., Ltd. was established, with the legal representative of He Xinyang and the registered capital of 10 million yuan. Its business scope includes: electronic product sales; Non-metallic minerals and products sales; Building materials sales, etc. Enterprise equity penetration shows that the company is wholly owned by Shennong Group.Wei Lanfeng became the vice president and chief operating officer of Porsche China, and Porsche announced that Philipp von Witzendorff will officially become the vice president and chief operating officer of Porsche China from January 1st, 2025. It is understood that in the past two years, Wei Lanfeng has served as President and CEO of Porsche Japan.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13